Dagher Ibrahim B.'s Form 4 filing
Brainstorm Cell Therapeutics Inc. (BCLI) · filed Jul 24, 2024
- Accession no.
- 0001104659-24-082328
- Filed
- Jul 24, 2024, 4:05 PM ET
- Trade date
- Jul 19, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $22.1K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dagher Ibrahim B.CIK 0002019599 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2024 | Common Stock | SSaleDisposed | −63,000 | $0.3503 | −$22,068.9 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.